Replies to post #93678 on $heff's $tation of $tocks & $olid DD

[DewDiligence]

Not impressed by RGLS’ HCV data—I concur with this opinion:

$RGLS Who would want an injectable that lead to SAEs and resistance mutations when there're safer oral rx available? pic.twitter.com/o2KgyILWsG

— Andy Biotech (@AndyBiotech) April 15, 2016

ENTA, on the other hand, released compelling HCV data this weekend (#msg-121968928).